Which scan spots prostate cancer better? new study compares two tracers
NCT ID NCT03604757
First seen May 20, 2026 · Last updated May 20, 2026
Summary
This study involved 22 men with prostate cancer who were scheduled for prostate removal surgery. Each participant received two different PET/CT scans using different tracers (68Ga-RM2 and 68Ga-PSMA-617) to see how well each tracer highlighted cancer cells. The goal was to compare the scans' ability to detect cancer, not to treat it. Results help doctors understand which imaging method might be more useful for planning surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bordeaux University Hospital
Bordeaux, 33076, France
Conditions
Explore the condition pages connected to this study.